ArticleMolecular diversity2025

Celastrol-Ligustrazine compound proven to be a novel drug candidate for idiopathic pulmonary fibrosis by intervening in the TGF-β1 mediated pathways-an experimental in vitro and vivo study.

Lu Gao et al.PubMed ↗Publisher ↗

No numbers read from the abstract.